Insight in France

Published within

« | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | ... | » »|

Type Product title / description Pub Price
Report
Report

Mobile Payments at the Service Station| Verdict Trend Report

This report analyses different types of mobile payments currently used by motorists,the average mobile payment spend and frequency used per motorist across 14 European markets and potential barriers to mobile payment usage that retailers face.

Published By Verdict
28 Jul 2015 $3450
Buy
Report
Report

2015 Big Pharma Outlook

This report explores and visualizes market dynamics in the Big Pharma peer set out to 2024, using in-house sales forecasts.

Published By Datamonitor
14 Jul 2015 $7500
Buy
Report
Report

Wealth in France: HNW Customers

Part of a two-part series, Wealth in France: HNW Customers analyzes the profile of French HNW individuals, from their investments to product demand to sources of wealth. This report is based on our 2014 Global Wealth Managers Survey.

Published By Datamonitor
09 Jul 2015 $3450
Buy
Report
Report

Profitability Assessment of Branded Generic Inhalers

In this report, we provide a regulatory and economic analysis in Europe and the US of branded generic inhalers.

Published By Datamonitor
01 Jul 2015 $9500
Buy
Report
Report

European Car Wash Market| Verdict Sector Report

Analysis of the commercial car wash market across seventeen European countries, including the number of car wash installations, total wash occasions per year, value of the market and insight into major trends impacting the sector.

Published By Verdict
15 Jun 2015 $5250
Buy
Report
Report

Immuno-Oncology Overview

This is an overview of the field of immuno-oncology and the various immuno-oncology classes. Immuno-oncology is one of the most promising and fastest growing areas of cancer research.

Published By Datamonitor
15 Jun 2015 $7500
Buy
Report
Report

Forecast: Rheumatoid Arthritis in the US, Japan, and 5EU

Datamonitor Healthcare uses a patient-based approach to size the rheumatoid arthritis (RA) market in the US, Japan, and five major EU markets from 2014 to 2023, focusing on traditional and biologic disease-modifying therapies.

Published By Datamonitor
24 Apr 2015 $2800
Buy
Report
Report

Treatment: Rheumatoid Arthritis

Through our in-house primary research, Datamonitor Healthcare has produced thorough analysis on rheumatoid arthritis (RA) treatment trends, outcomes, and unmet needs.

Published By Datamonitor
23 Apr 2015 $2800
Buy
Report
Report

Marketed Drugs: Rheumatoid Arthritis

Our marketed drugs analysis gives an overview of market behaviors as well as individual commercial and clinical attractiveness.

Published By Datamonitor
23 Apr 2015 $2800
Buy
Report
Report

Pipeline: Rheumatoid Arthritis

Our pipeline product analysis gives an overview of how pipeline products in general are expected to perform, as well as early-phase projections and individual pipeline forecasts.

Published By Datamonitor
21 Apr 2015 $2800
Buy

« | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | ... | » »|

No help is available.